$1.93
0.052.66%
At close: -
$1.96
0.031.56%
After Hours: 7:20 PM EDT
Track the latest Taysha Gene Therapies insider trading activity. Stay informed on recent buys, sells, and market impact for Taysha Gene Therapies stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Jul 01, 2024 | Paul Manning | — | 1.33M | $2.25 | $3.00M | BUY | 27.56% | 6.17M | Jun 27 | View |
Nov 20, 2023 | Paul Manning | 10% OWNER | 100.00K | $1.63 | $163.00K | BUY | 0.47% | 21.40M | Nov 17 | View |
Aug 25, 2023 | Kamran Alam | CHIEF FINANCIAL OFFICER | -33.00K | $2.33 | -$76.89K | SELL | -11.34% | 258.04K | Aug 24 | View |
Aug 16, 2023 | Paul Manning | 10% OWNER | 16.47M | $0.90 | $14.82M | BUY | 340.40% | 21.30M | Aug 16 | View |
Aug 16, 2023 | John Stalfort III | DIRECTOR | 827.78K | $0.90 | $700.00K | BUY | 373.54% | 1.05M | Aug 16 | View |
Aug 16, 2023 | Sean Nolan | CHIEF EXECUTIVE OFFICER | 444.44K | $0.90 | $400.00K | BUY | 40.69% | 1.54M | Aug 16 | View |
Aug 16, 2023 | Phillip Donenberg | DIRECTOR | 111.11K | $0.90 | $100.00K | BUY | 3703.70% | 114.11K | Aug 16 | View |
Jul 14, 2023 | R.A. Session II | — | -85.87K | $0.71 | -$60.77K | SELL | -0.94% | 9.01M | Jul 12 - Jul 13 | View |
Jun 26, 2023 | R.A. Session II | 10% OWNER | -28.61K | $0.70 | -$20.12K | SELL | -0.31% | 9.10M | Jun 22 - Jun 23 | View |
Jun 22, 2023 | R.A. Session II | 10% OWNER | -434.62K | $0.71 | -$307.84K | SELL | -4.55% | 9.13M | Jun 20 - Jun 21 | View |
May 18, 2023 | Sukumar Nagendran | PRESIDENT AND HEAD R&D | 5.00K | $0.68 | $3.40K | BUY | 17.11% | 34.23K | May 16 | View |
Nov 02, 2022 | Paul Manning | DIRECTOR | 1.50M | $2.00 | $3.00M | BUY | 44.95% | 4.84M | Oct 31 | View |
Aug 24, 2022 | Kamran Alam | CHIEF FINANCIAL OFFICER | -3.33K | $3.47 | -$11.54K | SELL | -1.23% | 266.12K | Aug 23 | View |
Aug 22, 2022 | Kamran Alam | CHIEF FINANCIAL OFFICER | -28.68K | $3.70 | -$106.00K | SELL | -9.62% | 269.45K | Aug 18 - Aug 22 | View |
Jul 07, 2022 | SUYASH PRASAD | CMO AND HEAD R&D | -12.86K | $3.70 | -$47.65K | SELL | -2.37% | 530.59K | Jul 05 - Jul 06 | View |
Jul 01, 2022 | SUYASH PRASAD | CMO AND HEAD R&D | -50.14K | $3.65 | -$183.08K | SELL | -8.45% | 543.45K | Jun 29 - Jul 01 | View |
Feb 04, 2022 | Paul Manning | DIRECTOR | 201.60K | $7.80 | $1.57M | BUY | 3.96% | 5.29M | Feb 02 - Feb 03 | View |
Feb 03, 2022 | Sukumar Nagendran | DIRECTOR | 10.00K | $8.01 | $80.10K | BUY | 52.01% | 29.23K | Feb 02 | View |
Feb 03, 2022 | Phillip Donenberg | DIRECTOR | 3.00K | $7.78 | $23.34K | BUY | ∞ | 3.00K | Feb 02 | View |
Dec 08, 2021 | RA Session II | PRESIDENT AND CEO | 42.52K | $12.44 | $529.10K | BUY | 0.46% | 9.33M | Nov 23 | View |
Nov 29, 2021 | Paul Manning | DIRECTOR | 2.20K | $13.19 | $29.04K | BUY | 0.11% | 2.05M | Nov 24 | View |
Nov 24, 2021 | Paul Manning | DIRECTOR | 20.00K | $12.54 | $250.80K | BUY | 0.98% | 2.05M | Nov 23 | View |
Aug 20, 2021 | Kamran Alam | CHIEF FINANCIAL OFFICER | -33.00K | $16.88 | -$557.02K | SELL | -9.97% | 298.12K | Aug 18 - Aug 20 | View |
Jul 01, 2021 | SUYASH PRASAD | CMO AND HEAD R&D | -79.00K | $22.63 | -$1.79M | SELL | -11.75% | 593.59K | Jun 29 - Jul 01 | View |
May 24, 2021 | Sean Nolan | DIRECTOR | 1.17K | $22.35 | $26.15K | BUY | 0.11% | 1.09M | May 20 | View |
May 17, 2021 | Paul Manning | DIRECTOR | 12.00K | $20.98 | $251.76K | BUY | 0.59% | 2.03M | May 14 | View |
Browse insider trades on all stocks.